Pfizer Diflucan Pediatric Extension Should Not Block Ranbaxy Generics, Lawsuit Says
This article was originally published in The Pink Sheet Daily
Executive Summary
A judge will hear arguments March 4 on Ranbaxy’s request for a preliminary injunction requiring FDA to immediately approve the company’s ANDAs for fluconazole tablets and oral suspension.